Gene: KRAS ×
Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913240
rs121913240
KRAS
A 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913529
rs121913529
KRAS
T 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371

2009
dbSNP: rs121913529
rs121913529
KRAS
T 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913529
rs121913529
KRAS
A 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371

2009
dbSNP: rs121913529
rs121913529
KRAS
A 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913530
rs121913530
KRAS
G 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913530
rs121913530
KRAS
T 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371

2009
dbSNP: rs121913530
rs121913530
KRAS
T 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913530
rs121913530
KRAS
G 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371

2009
dbSNP: rs121913530
rs121913530
KRAS
A 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371

2009
dbSNP: rs121913530
rs121913530
KRAS
A 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913535
rs121913535
KRAS
G 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913535
rs121913535
KRAS
T 0.700 CausalMutation CLINVAR Phase II trial of sorafenib in metastatic thyroid cancer. 19255327

2009
dbSNP: rs121913535
rs121913535
KRAS
G 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371

2009
dbSNP: rs121913535
rs121913535
KRAS
T 0.700 CausalMutation CLINVAR Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma. 19773371

2009
dbSNP: rs112445441
rs112445441
KRAS
T 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913238
rs121913238
KRAS
T 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913240
rs121913240
KRAS
C 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913240
rs121913240
KRAS
A 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913240
rs121913240
KRAS
G 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913529
rs121913529
KRAS
A 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913529
rs121913529
KRAS
T 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913530
rs121913530
KRAS
A 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913530
rs121913530
KRAS
G 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007
dbSNP: rs121913530
rs121913530
KRAS
T 0.700 CausalMutation CLINVAR Hyperactive Ras in developmental disorders and cancer. 17384584

2007